Personalised Healthcare FP7 Challenge 5: ICT for Health, Aging Well, Inclusion and Governance

Framework Programme 7 European Union Grant Funding for Research and Development Total funds = €54 billion Budget for Health Care = €30 billions Consortia comprising Universities, Research Institutes, and Business with bias for SMEs Projects selected on Scientific Objectives, Governance and Exploitation

Framework Programme 7 Focuses research on science led innovation De-risks medical device innovation thru funding high risk research and creating market pull, with dissemination. Encourages public/private/third sector collaboration. Drives commercial advantage for SMEs BUT DOES NOT Develop technologies/products Organise supply chains and marketing/distribution partnerships Prove commercial value Provide capital for exploitation of the research

Avantrasara Exploitation Manager for DiPAR - early stage diagnosis of Parkinsons Disease - funded Exploitation Manager for BrainAging - pending Exploitation Manager for NeuroTech - work in progress o Draft call in 2011 work plan o Objective ICT : Personal Health Systems (PHS)  Personal Health Systems for remote management of diseases, treatment and rehabilitation, outside hospitals and care centres.  Rehabilitation of stroke and neurological conditions: providing patient services at home, with telesupervision by health professionals as and when required.

NeuroTech - Objectives Monitoring and rehabilitation of early stage Neurodegenerative diseases in the home Research of environmental and behavioral influences impact on rate and extent of degeneration Focused use of medicines related to individual patients Virtual Hospital Assessment/Rehabilitation Laboratory o Patient monitoring/communication devices o Virtual Reality Immersion application o Total Patient Care application o Clinical Research Hub Up to €6 million, 36 month project commencing Jan 2012

NeuroTech -Consortium Avantrasara UK SME - Exploitation Manager Euroscience - Greece SME - Co-ordinator Manus - UK SME - Biomechanics Universities: o Rome -Genetics o Kaunas -Neurology o Lancaster - Genetics o Crete - Virtual Reality o Plymouth - ICT, GRID, Partners sought:- o Clinical lead, Device Manufacturer, Pharmaceuticals, Infrastructure, Ethics, Security

Post Project Opportunities Output is o Rehabilitation of neurodegenerative diseases o Personalised care for individual patients o Low cost, accessible care regardless of location o Improved accessibility of clinical specialists o Improved understanding of physiology/cognitive/motor function relationships o Faster and more effective on-going research o Faster and more effective development of treatments

Post Project Challenges Output isn't o Low cost personal devices for monitoring and 2 way communication o Scalable infrastructure - platforms, bandwidth, energy o Integration with domestic environment exploiting existing technologies o Smart user interfaces avoiding training and implementation o Security and ethics controls o Operating model for team based care management o Execution model for manufacturing, distribution, maintenance, marketing, sales

Summary FP7 enables research commercial businesses wouldn't otherwise undertake But how do the results get turned into products and services which deliver the benefits?